Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment

Corresponding Author

Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan

Correspondence

Norifumi Kawada, Department of Hepatology, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abenoku, Osaka 545-8585, Japan.

View original article

0 0 0 0 0 0 0

Comments (0)